Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C

Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C

Background and rationale. The REPLACE study (NCT01571583) investigated telaprevir-based triple therapy in patients who have recurrent genotype 1 hepatitis C virus (HCV) infection following liver transplantation and are on a stable immunosuppressant regimen of tacrolimus or cyclosporin A. Patients re...

全面介紹

書目詳細資料
Main Authors: Xavier Forns, Didier Samuel, David Mutimer, Stefano Fagiuoli, Miquel Navasa, Kosh Agarwal, Marina Berenguer, Massimo Colombo, Kerstin Herzer, Frederik Nevens, Bjorn Daems, Katrien Janssen, Sivi Ouwerkerk-Mahadevan, Holly Kimko, Erkki Lathouwers, James Witek, Rodica Van Solingen-Ristea
格式: Article
語言:English
出版: Elsevier 2016-07-01
叢編:Annals of Hepatology
主題:
Telaprevir
Hepatitis C infection
Liver transplant
在線閱讀:http://www.sciencedirect.com/science/article/pii/S1665268119311391

因特網

http://www.sciencedirect.com/science/article/pii/S1665268119311391

相似書籍